Inactive Instrument

Insiders TapImmune Inc. OTC Bulletin Board

Equities

US8760332002

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

15/05	Earnings Flash (MRKR) MARKER THERAPEUTICS Reports Q1 Revenue $1.2M	MT
15/05	Marker Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Marker Therapeutics, Inc. Receives Approval from United States Adopted Name, Council and International Nonproprietary Names Expert Committee for ?Neldaleucel? as Nonproprietary Name for MT-601	22/01	CI
Marker Therapeutics, Inc. Appoints Eliot M. Lurier as Interim Chief Financial Officer	04/23/04	CI
Marker Therapeutics, Inc. Appoints Monic Stuart, M.D., as Chief Medical Officer	08/23/08	CI
Marker Therapeutics, Inc. Announces Management Changes	29/23/29	CI
Marker Therapeutics, Inc. Announces Chief Executive Officer Changes	29/23/29	CI
Marker Therapeutics, Inc. Announces Mythili Koneru, to Resign as Chief Medical Officer, Effective as of April 9, 2023	17/23/17	CI
Marker Therapeutics, Inc. Announces Resignation of Anthony Kim as Chief Financial Officer, Effective September 30, 2022	27/22/27	CI
Marker Therapeutics, Inc. Announces Frederick Wasserman Will Not Stand for Reelection as Director	07/22/07	CI
Marker Therapeutics, Inc. Appoints Katharine Knobil, M.D., to Board of Directors	09/21/09	CI
Insider Trends: Insider Purchase of Marker Therapeutics Stock Prolongs 90-Day Positive Trend	19/21/19	MT
Insider Trends: Insider Purchase of Marker Therapeutics Stock Continues 90-Day Positive Trend	19/21/19	MT
Insider Trends: Marker Therapeutics Insider 90-Day Buying Trend Added to with Purchase	19/21/19	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	19/21/19	MT
Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Marker Therapeutics Stock	19/21/19	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	19/21/19	MT
Insider Trends: 90-Day Buying Trend Prolonged with Insider Purchase of Marker Therapeutics Stock	19/21/19	MT
Insider Trends: Insider Purchase Continues Marker Therapeutics Positive Trend	19/21/19	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	19/21/19	MT
Insider Trends: Insider Purchase Adds to Marker Therapeutics Positive Trend	19/21/19	MT
Insider Trends: Insider Buying Continued with Purchase of Marker Therapeutics Stock	19/21/19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders TapImmune Inc. OTC Bulletin Board

Equities

US8760332002

Insiders

Filters